Aspira Women's Health Inc.
AWH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | -0.00 | 0.03 |
| FCF Yield | -7.85% | -63.32% | -15,300.78% | -10.25% |
| EV / EBITDA | -1.00 | -2.13 | 0.13 | -3.39 |
| Quality | ||||
| ROIC | -44.88% | -149.83% | -89.70% | -393.01% |
| Gross Margin | 60.00% | 63.81% | 68.45% | 63.39% |
| Cash Conversion Ratio | 0.04 | 0.65 | 1.67 | 0.74 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.58% | 0.94% | 2.64% | 3.91% |
| Free Cash Flow Growth | 87.31% | 44.10% | -203.82% | 65.06% |
| Safety | ||||
| Net Debt / EBITDA | 0.78 | -0.61 | 0.14 | -0.47 |
| Interest Coverage | 121.46 | -139.23 | -231.43 | 64.74 |
| Efficiency | ||||
| Inventory Turnover | 3.27 | 3.19 | 2.77 | 2.64 |
| Cash Conversion Cycle | -97.83 | -104.22 | -105.64 | -155.36 |